Key facts
- It has raised $2.8M; the latest was Later Stage VC ($2.7M) in Nov 2025.
- Notable investors include European Commission, Lumo Labs, Caelestinus, Leistone, Cedars-Sinai Accelerator — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Healthplus.ai
- ·The full record, as it builds
Funding rounds
No funding rounds for Healthplus.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Healthplus.ai
Developer of a surgical patient risk management platform designed to enable proactive surgical care through personalized complication predictions. The company's AI-based cloud platform integrates with local EHR workflow and uses machine learning algorithms to aid clinical staff in predicting early warning of post-surgery infections and other major complications, enabling healthcare professionals to provide patients with prioritized health support and improved surgical outcomes at affordable costs.
- Sector
- Healthcare
- HQ
- Amsterdam, Netherlands
- Founded
- 2017
- Employees
- 15
- Website
- healthplus.ai/
- Ownership
- Privately Held (backing)
Healthplus.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Healthplus.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Healthplus.ai in its N-PORT filings yet. We sweep new filings monthly.